These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17341203)
1. Electroporation enhances radiation and doxorubicin-induced toxicity in solid tumor in vivo. Shil P; Kumar A; Vidyasagar PB; Mishra KP J Environ Pathol Toxicol Oncol; 2006; 25(4):625-32. PubMed ID: 17341203 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiation cytotoxicity in murine cancer cells by electroporation: in vitro and in vivo studies. Shil P; Sanghvi SH; Vidyasagar PB; Mishra KP J Environ Pathol Toxicol Oncol; 2005; 24(4):291-8. PubMed ID: 16393122 [TBL] [Abstract][Full Text] [Related]
3. Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model. Maswadeh HM; Aljarbou AN; Alorainy MS; Rahmani AH; Khan MA Int J Nanomedicine; 2015; 10():2847-55. PubMed ID: 25926730 [TBL] [Abstract][Full Text] [Related]
4. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo). Meschini S; Condello M; Lista P; Vincenzi B; Baldi A; Citro G; Arancia G; Spugnini EP Eur J Cancer; 2012 Sep; 48(14):2236-43. PubMed ID: 22240284 [TBL] [Abstract][Full Text] [Related]
5. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Sersa G; Jarm T; Kotnik T; Coer A; Podkrajsek M; Sentjurc M; Miklavcic D; Kadivec M; Kranjc S; Secerov A; Cemazar M Br J Cancer; 2008 Jan; 98(2):388-98. PubMed ID: 18182988 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of nigericin and 5-(N-ethyl-N-isopropyl)amiloride: an approach to therapy based on cellular acidification and the inhibition of regulation of intracellular pH. Hasuda K; Lee C; Tannock IF Oncol Res; 1994; 6(6):259-68. PubMed ID: 7865901 [TBL] [Abstract][Full Text] [Related]
7. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model. Kranjc S; Tevz G; Kamensek U; Vidic S; Cemazar M; Sersa G Radiat Res; 2009 Dec; 172(6):677-85. PubMed ID: 19929414 [TBL] [Abstract][Full Text] [Related]
8. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Herman TS; Teicher BA; Coleman CN Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171 [TBL] [Abstract][Full Text] [Related]
9. Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential? Distelmans W; Van Ginckel R; Vanherck W; Willebrords R; Wouters L; De Brabander M; Mesens J Anticancer Res; 1991; 11(1):253-6. PubMed ID: 2018359 [TBL] [Abstract][Full Text] [Related]
10. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Ning S; Macleod K; Abra RM; Huang AH; Hahn GM Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030 [TBL] [Abstract][Full Text] [Related]
11. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227 [TBL] [Abstract][Full Text] [Related]
12. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range. Grdina DJ; Thames HD; Milas L Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):379-83. PubMed ID: 6706731 [TBL] [Abstract][Full Text] [Related]
13. miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux. Jain N; Das B; Mallick B DNA Repair (Amst); 2022 Jan; 109():103259. PubMed ID: 34871862 [TBL] [Abstract][Full Text] [Related]
14. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models. Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612 [TBL] [Abstract][Full Text] [Related]
15. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin. Kranjc S; Cemazar M; Grosel A; Scancar J; Sersa G Anticancer Res; 2003; 23(1A):275-81. PubMed ID: 12680224 [TBL] [Abstract][Full Text] [Related]
16. Effect of intratumoral injection on the biodistribution and therapeutic potential of novel chemophor EL-modified single-walled nanotube loading doxorubicin. Liu H; Xu H; Wang Y; He Z; Li S Drug Dev Ind Pharm; 2012 Sep; 38(9):1031-8. PubMed ID: 22794192 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113 [TBL] [Abstract][Full Text] [Related]
18. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Wong HL; Rauth AM; Bendayan R; Wu XY Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986 [TBL] [Abstract][Full Text] [Related]
20. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice. Chu AM; Fowler JF Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]